Trial Profile
A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs SK 1405 (Primary)
- Indications Pruritus
- Focus Pharmacodynamics
- Sponsors Sanwa Kagaku Kenkyusho
- 10 Apr 2016 Status changed from recruiting to completed.
- 18 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 09 Feb 2016 New trial record